Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis

Recruiting now

Conditions studied: Open-Angle Glaucoma

In brief

Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis

Key facts

Study ID

NCT06953349

Run by

Barnet Dulaney Perkins Eye Centers

People needed

300

Starts

2025-03-31

Expected to finish

2025-12-31

Last updated by the study team

2025-05-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects with h/o CEIOL/OMNI/Hydrus (chosen based on subjects on more than 1 medication pre-operatively) with at least 3 years of follow up data
• have Glaucoma

You may not qualify if…

• Patients with angle closure glaucoma or secondary forms of glaucoma due to neovascularization of the angle, uveitic glaucoma, congenital glaucoma, or glaucoma due to congenital anomalies.
• Patients with refractory CME or CME persisting 3 months or more post-operatively
• Patients with incomplete IOP, medication logs or VF data within post-operative period
• Prior incisional surgery or MIGS

Where it is running

• Barnet Dulaney Perkins Eye Center — Mesa, Arizona, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.